French Registry of CMR Late Gadolinium Enhancement in Myocarditis

Retrospective French Registry of Cardiovascular Magnetic Resonance Late Gadolinium Enhancement in Patients With Myocarditis

Status

Not yet recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT07394543

Acronym

MYOCARDITI-LGE

Enrollment

5000

Registered

2026-02-06

Start date

2026-02-10

Completion date

2036-02-10

Last updated

2026-02-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myocarditis Acute

Keywords

Late Gadolinium Enhancement, Myocarditis

Brief summary

Acute myocarditis is a major cause of death in young adults and carries substantial morbidity, including a significant risk of progression to dilated cardiomyopathy. Current diagnostic and therapeutic strategies remain poorly defined, making risk stratification crucial to enable personalized treatments and reduce mortality and major cardiovascular events.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

1. Age ≥ 18 years 2. Ability to provide informed non-opposition 3. AM diagnosis confirmed using CMR, fulfilling the modified Lake Louise diagnostic criteria

Exclusion criteria

1\. Patients unable to provide informed non-opposition.

Design outcomes

Primary

Measure	Time frame	Description
All-cause mortality	From enrollment to the end of follow up at 10 years	All-cause mortality defined using the French national registry of death (INSEE).

Secondary

Measure	Time frame
All-cause death	From enrollment to the end of follow up at 10 years
Heart transplantation	From enrollment to the end of follow up at 10 years
Ventricular arrhythmia	From enrollment to the end of follow up at 10 years
Hospitalisation for acute heart failure	From enrollment to the end of follow up at 10 years

Contacts

CONTACTThéo PEZEL, Dr

theo.pezel@aphp.fr+33 6 68 72 24 89

Outcome results